UBRELVY® – A First-In-Class Therapy for the Treatment of Migraines
Drug Review: Volume 23, Issue 6 (PDF) Migraines are a class of debilitating headaches that reduce patients’ quality of life, work performance and productivity. It is the second leading cause of disability worldwide. Migraines affect approximately 8.3% of the Canadian population. They are characterized by a throbbing headache on one side of the head, associated […]